These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7258106)

  • 1. Hemodynamic evaluation of vasodilator drug therapy in primary pulmonary hypertension.
    Gould L; Chokshi AB; Patel S; Gomes GI
    Am Heart J; 1981 Aug; 102(2):300. PubMed ID: 7258106
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential hemodynamic response to vasodilators in a patient with pulmonary hypertension: case report.
    Zaloga GP; Hughes P; Cohen D; Chernow B; Rainey TG; Lake CR
    Mil Med; 1983 May; 148(5):426-9. PubMed ID: 6408523
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vasodilator therapy in pulmonary arterial hypertension of unknown cause (primary)].
    Lupi Herrera E
    Arch Inst Cardiol Mex; 1982; 52(3):189-90. PubMed ID: 7114962
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of acute hemodynamic responses to prostacyclin with standard vasodilators in patients with primary pulmonary hypertension.
    Palevsky HI; Fishman AP
    Chest; 1988 Mar; 93(3 Suppl):179S. PubMed ID: 3277819
    [No Abstract]   [Full Text] [Related]  

  • 5. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
    Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vasodilators in "primary" pulmonary hypertension?].
    Morpurgo M
    G Ital Cardiol; 1990 Feb; 20(2):123-25. PubMed ID: 2328865
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vasodilator agents in pulmonary hypertension].
    Farga V
    Rev Med Chil; 1987 Sep; 115(9):902-4. PubMed ID: 3506285
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasodilator therapy in primary pulmonary hypertension.
    Elkayam U
    Chest; 1981 Mar; 79(3):253-4. PubMed ID: 7471853
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasodilator therapy for primary pulmonary hypertension.
    McGoon MD; Vlietstra RE
    Mayo Clin Proc; 1984 Oct; 59(10):672-7. PubMed ID: 6148467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the effects of vasodilator therapy in primary pulmonary hypertension. Experience in 7 cases].
    Lanzarini L; Gavazzi A; Mussini A; Graziano G; Campana C; Bargiggia G; Angoli L; Aimè E; Arbustini E; Montemartini C
    G Ital Cardiol; 1990 Feb; 20(2):114-22. PubMed ID: 2328864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of vasodilator therapy for pulmonary arterial hypertension.
    Rubin LJ
    Clin Chest Med; 1983 May; 4(2):309-19. PubMed ID: 6342925
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of pulmonary hypertension with vasodilation agents].
    Tschopp JM
    Schweiz Rundsch Med Prax; 1984 Jun; 73(25):789-91. PubMed ID: 6473980
    [No Abstract]   [Full Text] [Related]  

  • 13. Viagra for impotence of pulmonary vasodilator therapy?
    Lodato RF
    Am J Respir Crit Care Med; 2001 Feb; 163(2):312-3. PubMed ID: 11179097
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasodilator therapy for primary pulmonary hypertension. Limitations and hazards.
    Packer M
    Ann Intern Med; 1985 Aug; 103(2):258-70. PubMed ID: 2861770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orally active prostacyclin analogue in primary pulmonary hypertension.
    Okano Y; Yoshioka T; Shimouchi A; Satoh T; Kunieda T
    Lancet; 1997 May; 349(9062):1365. PubMed ID: 9149701
    [No Abstract]   [Full Text] [Related]  

  • 16. Hope in primary pulmonary hypertension.
    Reeves JT
    N Engl J Med; 1980 Jan; 302(2):112-3. PubMed ID: 7350416
    [No Abstract]   [Full Text] [Related]  

  • 17. Beneficial hemodynamic effects of oral prostacyclin (PGI2) analogue, beraprost sodium, on a patient with primary pulmonary hypertension--a case report.
    Hashida H; Hamada M; Shigematsu Y; Ikeda S; Kuwahara T; Kawakami H; Hara Y; Kodama K; Kohara K; Hiwada K
    Angiology; 1998 Feb; 49(2):161-4. PubMed ID: 9482517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot study.
    Kleber FX; Bollmann T; Borst MM; Costard-Jäckle A; Ewert R; Kivikko M; Petterson T; Pohjanjousi P; Sonntag S; Wikström G
    J Clin Pharmacol; 2009 Jan; 49(1):109-15. PubMed ID: 18981240
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics.
    Mahowald ML; Weir EK; Ridley DJ; Messner RP
    J Rheumatol; 1985 Aug; 12(4):773-7. PubMed ID: 4057200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E1 as a screening vasodilator in primary pulmonary hypertension.
    Halpern SM; Shah PK; Lehrman S; Goldberg HS; Jasper AC; Koerner SK
    Chest; 1987 Oct; 92(4):686-91. PubMed ID: 3652754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.